SCI & TECH● LOWJun 22 · Jun 22, 2026, 5:04 AM
Insilico partners with SK Biopharmaceuticals in $2.5B AI drug pact
Seeking Alpha Tech
Insilico has partnered with SK Biopharmaceuticals in a $2.5 billion agreement focused on AI drug development. This represents a major collaboration in the pharmaceutical and artificial intelligence fields.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH43m agoTesla shows off a flying Roadster that can drive upside downSeeking Alpha TechSCI & TECH1h agoTapping into tech and talentSouth China Morning PostSCI & TECH1h agoNvidia CEO assures that AI will make electricians, plumbers and bricklayers some of the best-paid jobs because the world will need to build the infrastructure that will make its expansion possibleClarínSCI & TECH1h ago Crystal Lake : What is Argonaut ? mashable.com · United States